Related Experiment Video
Updated: Nov 16, 2025

13:02
Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
Published on: November 4, 2017
8.9K
A Multifactorial Model of Multiple Sclerosis Gait and Its Changes Across Different Disability Levels
IEEE Transactions on Bio-Medical Engineering
|February 24, 2021
Summary
A new gait model for people with Multiple Sclerosis (pwMS) identifies key factors of mobility impairment. This validated model reveals subtle gait changes across disability levels, aiding clinical assessment and monitoring.
Area of Science:
- Neurology
- Biomedical Engineering
- Rehabilitation Science
Background:
- Mobility assessment is crucial for managing Multiple Sclerosis (MS).
- Instrumented gait analysis offers detailed metrics but lacks a specific model for MS-related gait deterioration.
- A validated gait model is needed to understand and quantify gait impairments in people with MS (pwMS).
Purpose of the Study:
- To develop and validate a gait model for discriminating underlying features of gait deterioration in pwMS.
- To characterize gait impairment across different disability levels in pwMS using the developed model.
Main Methods:
- Gait data collected from 114 pwMS (mild, moderate, severe disability) and 24 healthy controls using inertial sensors.
- Exploratory and confirmatory factor analysis applied to 36 gait metrics derived from 6-minute walk tests.
- Model validation through characterization of gait impairment across disability groups.
Main Results:
- A five-domain gait model was developed: rhythm/variability, pace, asymmetry, forward dynamic balance, and lateral dynamic balance.
- Significant gait alterations in rhythm/variability, asymmetry, and pace were observed even in the mild disability group.
- Dynamic balance deterioration was evident in moderate and severe disability groups.
Conclusions:
- A conceptual gait model for disease-specific mobility assessment in pwMS was successfully developed and validated.
- The model effectively highlights clinically relevant gait changes across all disability levels, including those with subclinical impairment.
- This model shows potential as a monitoring biomarker for pwMS.

